Abstract:Introduction and objective: Precisely and sensitively diagnosing diseases especially early and accurate tumor diagnosis in clinical magnetic resonance (MR) scanner is a highly demanding but challenging task. Gadolinium (Gd) chelate is the most common T-1 magnetic resonance imaging (MRI) contrast agent at present. However, traditional Gd-chelates are suffering from low relaxivity, which hampers its application in clinical diagnosis. Currently, the development of nano-sized Gd based T-1 contrast agent, such as incorporating gadolinium chelate into nanocarriers, is an attractive and feasible strategy to enhance the T-1 contrast capacity of Gd chelate. The objective of this study is to improve the T-1 contrast ability of Gd-chelate by synthesizing nanoparticles (NPs) for accurate and early diagnosis in clinical diseases. Methods: Reverse microemulsion method was used to coat iron oxide (IO) with tunable silica shell and form cores of NPs IO@SiO2 at step one, then Gd-chelate was loaded on the surface of silica-coated iron oxide NPs. Finally, Gd-based silica coating magnetite NPs IO@SiO2-DTPA-Gd was developed and tested the ability to detect tumor cells on the cellular and in vivo level. Results: The r(1) value of IO@SiO2-DTPA-Gd NPs with the silica shell thickness of 12 nm was about 33.6 mM(-1)s(-1), which was approximately 6 times higher than Gd-DTPA, and based on its high T-1 contrast ability, IO@SiO2-DTPA-Gd NPs could effectively detect tumor cells on the cellular and in vivo level. Conclusion: Our findings revealed the improvement of T-1 relaxation was not only because of the increase of molecular tumbling time caused by the IO@SiO2 nanocarrier but also the generated magnetic field caused by the JO core. This nanostructure with high T-1 contrast ability may open a new approach to construct high-performance T-1 contrast agent.

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor T 1 Magnetic Resonance Imaging

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging

Gadolinium-based contrast agents for tumor targeting imaging

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Single‐Atom Gd Nanoprobes for Self‐Confirmative MRI with Robust Stability

Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T(1) contrast ability.

Ten-Gram-Scale Facile Synthesis of Organogadolinium Complex Nanoparticles for Tumor Diagnosis.

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Gadolinium-based Nanoscale MRI Contrast Agents for Tumor Imaging

Improving Longitudinal Transversal Relaxation of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity

Chiral Gd-DOTA as a Versatile Platform for Hepatobiliary and Tumor Targeting MRI Contrast Agents

Albumin-based Nanoparticles Loaded with Hydrophobic Gadolinium Chelates As T1-T2 Dual-Mode Contrast Agents for Accurate Liver Tumor Imaging.

[Gadolinium-Loaded Nanoparticle As a Novel Molecular Imaging Contrast Agent for Magnetic Resonance Imaging].

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Gadolinium-Incorporated Carbon Nanodots for T1-Weighted Magnetic Resonance Imaging